Trials / Completed
CompletedNCT02497352
Effects of Flaxseed Supplementation in Metabolic Syndrome
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effects of flaxseed supplementation on fasting blood sugar, lipid profile and anthropocentric measurements in subjects with metabolic syndrome, in a randomized, open-labeled, controlled pilot study, 44 subjects with metabolic syndrome will be received 30g/d flaxseed with lifestyle modification or lifestyle modification alone for 12 weeks. Both groups will be advised to follow an energy balanced diet and physical activity recommendations. Parameters related to metabolic syndrome will be measured at the baseline and at the end of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | flaxseed | |
| BEHAVIORAL | lifestyle modification |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2014-08-01
- First posted
- 2015-07-14
- Last updated
- 2015-07-14
Source: ClinicalTrials.gov record NCT02497352. Inclusion in this directory is not an endorsement.